FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for alprazolam from Sandoz Inc, updating the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)